Alasdair J Coles

16PUBLICATIONS
56CO-AUTHORS
Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Predictive and prognostic markersClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 24, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

|May 13, 2026
Low-dose IL-2 fails to expand Tregs after alemtuzumab: insight into impaired immune tolerance in multiple sclerosis.

|Dec 08, 2025
The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy.

Gioia Riboni-Verri, Christopher E McMurran, Trisha Mukherjee

|Oct 06, 2025
Ageing and remyelination failure in people with multiple sclerosis.

Trisha Mukherjee, Christopher E McMurran, Jonathon Holland

|Sep 15, 2025
Biosimilar rollouts: practice, pitfalls and the importance of effective communication.

Ruth Dobson, Rachel Dorsey, James Varley

|Aug 04, 2025
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.

Tomas Kalincik, Sifat Sharmin, Izanne Roos

Pageof 3

Frequent Collaborators

5 joint publications

Nick G Cunniffe

4 joint publications

Christopher E McMurran

4 joint publications

J William L Brown

3 joint publications

Declan T Chard